PDGFRA and neoplasm: In conclusion, our integrative genomic and transcriptomic analysis highlights PDGFRA as a potential therapeutic target, owing to its high mutation frequency, elevated expression in specific OPC‐like subpopulations, and tumor‐driving potential.